| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.21 | 0.2 |